Literature DB >> 9823910

Current management of acute leg ischaemia: results of an audit by the Vascular Surgical Society of Great Britain and Ireland.

W B Campbell1, B M Ridler, T H Szymanska.   

Abstract

BACKGROUND: Management of acute leg ischaemia has changed in recent years. This study aimed to elucidate current practice throughout the UK and Ireland.
METHODS: Surgeons and audit departments were asked to return a questionnaire about every episode of acute leg ischaemia seen in the hospital between 1 January and 31 March 1996.
RESULTS: A total of 539 episodes were reported in 474 patients (248 men) aged 19-96 (median 73) years. Common causes were thrombosis in situ (41 per cent), embolism (38 per cent) and graft or angioplasty occlusion (15 per cent). Vascular surgical advice was requested in 95 per cent of cases. Initial management was: immediate embolectomy in 21 per cent, anticoagulants in 13 per cent and no vascular intervention in 10 per cent. Arteriography was done in 56 per cent, followed by 186 endovascular and 165 surgical interventions. At 30 days, 70 per cent of limbs were definitely viable and 16 per cent had been amputated. The mortality rate was 22 per cent. Cases were reported by 86 of 182 hospitals contacted, but some referred no patients, and a supplementary audit of 54 cases (10 per cent size of the original sample) from non-contributing hospitals showed no important differences.
CONCLUSION: Patients with acute leg ischaemia are generally treated by vascular specialists, with modern methods and acceptable results. This is being achieved despite insufficient vascular surgeons and radiologists for formal emergency rotas in most hospitals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9823910     DOI: 10.1046/j.1365-2168.1998.00906.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  8 in total

1.  Regional vascular surgical units: a practical means of providing specialist services.

Authors:  M R Kalbassi; S Tierney; P A Grace; P E Burke
Journal:  Ir J Med Sci       Date:  2000 Apr-Jun       Impact factor: 1.568

2.  Risk Factors for Long-Term Mortality and Amputation after Open and Endovascular Treatment of Acute Limb Ischemia.

Authors:  Elizabeth A Genovese; Rabih A Chaer; Ashraf G Taha; Luke K Marone; Efthymios Avgerinos; Michel S Makaroun; Donald T Baril
Journal:  Ann Vasc Surg       Date:  2015-11-10       Impact factor: 1.466

3.  Surgery versus thrombolysis for initial management of acute limb ischaemia.

Authors:  Rosemary Darwood; David C Berridge; David O Kessel; Iain Robertson; Rachel Forster
Journal:  Cochrane Database Syst Rev       Date:  2018-08-10

4.  Upper Limb Ischemia: Clinical Experiences of Acute and Chronic Upper Limb Ischemia in a Single Center.

Authors:  Miju Bae; Sung Woon Chung; Chung Won Lee; Jinseok Choi; Seunghwan Song; Sang-Pil Kim
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2015-08-05

5.  Patient delay is the main cause of treatment delay in acute limb ischemia: an investigation of pre- and in-hospital time delay.

Authors:  Louise S Londero; Birgitte Nørgaard; Kim Houlind
Journal:  World J Emerg Surg       Date:  2014-11-05       Impact factor: 5.469

6.  Successful surgical treatment for huge retroperitoneal liposarcoma involving the pancreas, right kidney, abdominal aorta and inferior vena cava.

Authors:  Mariko Tanaka; Toshiyasu Kawahara; Takahiro Nishikoshi; Masahiro Hagiwara; Koji Imai; Kimiharu Hasegawa; Atsuhiro Koya; Naoto Matsuno; Hidehiro Takei; Nobuyoshi Azuma; Hiroyuki Furukawa
Journal:  J Surg Case Rep       Date:  2017-11-23

7.  Combined treatment (image-guided thrombectomy and endovascular therapy with open femoral access) for acute lower limb ischemia: Clinical efficacy and outcomes.

Authors:  Soo Buem Cho; Ho Cheol Choi; Sang Min Lee; Jae Boem Na; Mi Jung Park; Hwa Seon Shin; Jung Ho Won; Chung Eun Lee; Sung Eun Park
Journal:  PLoS One       Date:  2019-11-15       Impact factor: 3.240

8.  Administration of FTY720 during Tourniquet-Induced Limb Ischemia Reperfusion Injury Attenuates Systemic Inflammation.

Authors:  Anthony D Foster; Diego Vicente; Jonathan J Sexton; Luke Johnston; Nick Clark; Crystal Leonhardt; Eric A Elster; Thomas A Davis; Matthew J Bradley
Journal:  Mediators Inflamm       Date:  2017-12-19       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.